Myriad Genetics

E133679

biotechnology company public company

Myriad Genetics is a biotechnology company best known for developing and commercializing genetic tests, particularly for assessing inherited cancer risk.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (2)

Label	Occurrences
Myriad Genetics canonical	1
Myriad Genetics, Inc.	1

Statements (49)

Predicate	Object
instanceOf	biotechnology company ⓘ public company ⓘ
businessModel	commercial genetic testing services ⓘ
country	United States of America ⓘ surface form: United States
fieldOfWork	genomics ⓘ molecular diagnostics ⓘ oncology diagnostics ⓘ personalized medicine ⓘ
focusesOn	prognostic testing in oncology ⓘ risk assessment for inherited diseases ⓘ treatment selection using genetic information ⓘ
foundedBy	John Huntsman Sr. ⓘ Mark Skolnick ⓘ Per Peterson ⓘ Peter Meldrum ⓘ Walter Gilbert ⓘ
hasLaboratory	CAP-accredited laboratory ⓘ CLIA-certified laboratory ⓘ
hasResearchFocus	DNA sequencing ⓘ biomarker discovery ⓘ companion diagnostics for targeted therapies ⓘ hereditary breast cancer ⓘ hereditary colorectal cancer ⓘ hereditary ovarian cancer ⓘ hereditary prostate cancer ⓘ
headquartersLocation	Salt Lake City ⓘ surface form: Salt Lake City, Utah, United States
inception	1991 ⓘ
industry	biotechnology ⓘ genetic testing ⓘ
involvedIn	U.S. Supreme Court decision on gene patents ⓘ
legalCase	Association for Molecular Pathology v. Myriad Genetics, Inc. ⓘ
legalIssue	patentability of human genes ⓘ
listedOn	NASDAQ ⓘ
notableFor	BRCA1 and BRCA2 genetic testing ⓘ development of genetic tests for inherited cancer risk ⓘ
offersTo	clinical laboratories ⓘ healthcare providers ⓘ patients through physician orders ⓘ
productOrService	companion diagnostic tests ⓘ hereditary cancer risk tests ⓘ pharmacogenomic tests ⓘ prenatal genetic tests ⓘ psychiatric pharmacogenetic tests ⓘ
regulatoryBody	Centers for Medicare & Medicaid Services ⓘ Food and Drug Administration ⓘ surface form: U.S. Food and Drug Administration
tickerSymbol	MYGN ⓘ
usesTechnology	Sanger sequencing ⓘ bioinformatics analysis of genomic data ⓘ next-generation sequencing ⓘ

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Walter Gilbert → coFounderOf → Myriad Genetics ⓘ

Association for Molecular Pathology v. Myriad Genetics, Inc. → respondent → Myriad Genetics ⓘ

this entity surface form: Myriad Genetics, Inc.